U.S. authorizes Pfizer vaccine for 12 to 15-year-olds

U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination rates have slowed significantly. Flora Bradley-Watson reports.